Accelerating drug discovery with AI: Insights from Isomorphic Labs
Gradient Dissent: Conversations on AI
Challenges in Drug Design Process
Improving efficiency and accuracy in drug design is crucial, but developing a drug from identifying a target to ensuring efficacy and safety presents significant challenges. Setting realistic expectations regarding the complexity of the process is essential. Isomorphic Labs has made significant progress in developing their technology platform in the past two years, with ongoing drug design programs and partnerships with industry players like Eli Lilly and Novartis. Despite steady progress, the drug discovery journey is at an early stage, and navigating through the multifaceted challenges remains a priority.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
